Collaborative Expert LLMs Guided Multi-Objective Molecular Optimization

📅 2025-03-05
📈 Citations: 0
Influential: 0
📄 PDF
🤖 AI Summary
Molecular multi-objective optimization remains a critical bottleneck in drug discovery; conventional trial-and-error approaches are inefficient, while existing AI methods struggle to simultaneously optimize multiple pharmacologically relevant properties—such as selectivity and bioavailability. To address this, we propose MultiMol, the first dual-agent collaborative large language model (LLM) framework for molecular design. The generation agent performs data-driven molecular graph modeling and Pareto-optimal frontier search over multiple objectives, while the research agent enables scientific guidance via dynamic literature retrieval and knowledge distillation. The system integrates experimental-data fine-tuning, instruction tuning, and joint property prediction. Evaluated on six benchmark tasks, MultiMol achieves an 82.30% success rate—surpassing the prior state-of-the-art (27.50%). It further demonstrates practical utility by enhancing XAC’s selectivity for the A1 adenosine receptor and improving Saquinavir’s oral bioavailability, thereby advancing knowledge-enhanced, multi-objective molecular design.

Technology Category

Application Category

📝 Abstract
Molecular optimization is a crucial yet complex and time-intensive process that often acts as a bottleneck for drug development. Traditional methods rely heavily on trial and error, making multi-objective optimization both time-consuming and resource-intensive. Current AI-based methods have shown limited success in handling multi-objective optimization tasks, hampering their practical utilization. To address this challenge, we present MultiMol, a collaborative large language model (LLM) system designed to guide multi-objective molecular optimization. MultiMol comprises two agents, including a data-driven worker agent and a literature-guided research agent. The data-driven worker agent is a large language model being fine-tuned to learn how to generate optimized molecules considering multiple objectives, while the literature-guided research agent is responsible for searching task-related literature to find useful prior knowledge that facilitates identifying the most promising optimized candidates. In evaluations across six multi-objective optimization tasks, MultiMol significantly outperforms existing methods, achieving a 82.30% success rate, in sharp contrast to the 27.50% success rate of current strongest methods. To further validate its practical impact, we tested MultiMol on two real-world challenges. First, we enhanced the selectivity of Xanthine Amine Congener (XAC), a promiscuous ligand that binds both A1R and A2AR, successfully biasing it towards A1R. Second, we improved the bioavailability of Saquinavir, an HIV-1 protease inhibitor with known bioavailability limitations. Overall, these results indicate that MultiMol represents a highly promising approach for multi-objective molecular optimization, holding great potential to accelerate the drug development process and contribute to the advancement of pharmaceutical research.
Problem

Research questions and friction points this paper is trying to address.

Addresses multi-objective molecular optimization challenges in drug development.
Introduces MultiMol, a collaborative LLM system for molecular optimization.
Demonstrates superior performance in optimizing molecules for real-world applications.
Innovation

Methods, ideas, or system contributions that make the work stand out.

Collaborative LLM system for molecular optimization
Data-driven and literature-guided agents integration
Enhanced success rate in multi-objective tasks
🔎 Similar Papers
No similar papers found.